🚀 At ArgusEye, we are dedicated to revolutionizing biopharmaceutical processing with our Auga™ platform. By offering real-time monitoring of critical parameters, we provide rapid and accurate quality data within seconds, driving faster and more efficient production of biological drugs. Discover how Auga™ is accelerating the future of biotech 👇 https://lnkd.in/d8CsAv4c #biotechinnovation #biopharma #processoptimization #qualitycontrol #augaplatform
ArgusEye
Forskning inom bioteknik
Linköping, Östergötland County 1 163 följare
Real-time Monitoring of Biological Systems and Processes
Om oss
ArgusEye provides innovative sensor systems based on nanoplasmonic detection for real-time monitoring of biological systems and processes.
- Webbplats
-
https://www.arguseye.se/
Extern länk för ArgusEye
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 2–10 anställda
- Huvudkontor
- Linköping, Östergötland County
- Typ
- Privatägt företag
- Grundat
- 2017
Adresser
-
Primär
Fridtunagatan 24
Linköping, Östergötland County 58213, SE
Anställda på ArgusEye
Uppdateringar
-
🌟 Two rewarding and valuable weeks on the East Coast of the US concluded with a successful pitch win for ArgusEye! After a successful start at the BioProcess International conference in Boston, our COO Nathalie Elsässer, has been in New York for a few days. There, she took part in the 2024 InnovativeNordics Acceleration Program, where ArgusEye was chosen as one of the participating companies. The program has provided valuable opportunities, productive meetings, and new insights. We have engaged in activities and gatherings, forming good contacts that can help us quickly establish ourselves ahead of an upcoming US launch. We also had the opportunity to meet companies that have gone through a similar expansion journey, as well as companies that specialize in bringing international companies to the US. Through the program, we have received relevant leads to potential clients and insights into various aspects, from tax law to employment. On the last day, we had company pitches, where participants had the chance to pitch in front of industry experts, investors, and other relevant companies. Elsässer made a great pitch, resulting in a win for ArgusEye! As part of our award, we received a SACCNY membership and an office location in New York – the perfect kick-start to our US-expansion. We are excited about the next step in our expansion and establishing our cutting-edge technology in the US market. 🚀
-
✨Say hello to Jakob, our latest addition to the ArgusEye team!✨ Jakob is one of our new R&D Lab Engineers. With a master's degree in sensors and materials, he will bring valuable knowledge and experience to our development team. Welcome to ArgusEye, Jakob – we are thrilled to have you with us! Get to know Jakob 👇 #welcome #team #expansion #innovation
-
✨ This year's edition of BioProcess International has now come to an end. It has been a valuable couple of days, filled with informative sessions, networking opportunities, and great encounters. Yesterday, Prof. Daniel Aili, Co-founder and Chairman of ArgusEyes, took the stage to discuss the Real-Time Analytical Solution for Optimizing Upstream mAb Bioprocessing. The response was fantastic, marked by valuable and engaging discussions. These days have not only provided us with new insights, but have also confirmed the challenges and needs that the pharmaceutical industry is currently facing. These are challenges and needs that we at ArgusEye are actively working to address. “Monoclonal antibodies (mAbs) still dominates the industry, whilst there there is a growing focus on cell and gene therapy. At the same time continuous manufacturing is being implemented more rapidly than before. As a stepping stone, intensified processing and automation are becoming increasingly important, and many technologies that were previously only presented in the literature are now being put into practice. In this, the need for accurate real-time data throughout the process is becoming increasingly important to achieve more efficient and controlled processes” – COO Nathalie Elsässer. Thank you to everyone who took the time to visit our booth and talk to us. Special thanks to BioProcess International for organizing a great conference. The journey continues for ArgusEyes as our COO, Nathalie Elsässer, heads to New York to participate in the 2024 InnovativeNordics Acceleration Program. This marks an important step in our expansion in the US market. We look forward to meeting you! Please feel free to contact Nathalie to schedule a meeting. #bioprocessinternational #BPI2024 #BPICONF #biotechweekboston #innovation #expansion #InnovativeNordics2024
-
Touchdown Boston and BioProcess International! ✈️ We are currently at BioProcess International in Boston and are eagerly anticipating the opportunities in the days ahead. Our COO Nathalie Elsässer, Application Scientist Ana Pinheiro, Ph.D., and Co-founder and Chairman Prof. Daniel Aili have set up our booth and are excited to meet many of you! 📍Visit us at booth 900 and be sure to catch Prof. Daniel Aili's speech on September 26. #bioprocessinternational #BPI2024 #BPICONF #biotechweekboston #innovation #biopharma
-
✨We are thrilled to welcome Elin to our growing team!✨ As Communications Officer and Community Manager at ArgusEye, Elin will focus on strengthening our brand and team. Welcome to ArgusEye, Elin – we are excited to have you with us! Get to know Elin 👇 #welcome #team #expansion #innovation
-
What is AugaOne™? And for whom is the system made for? 💡 These are some of the questions answered by CEO Dr. Erik Martinsson and Product Manager Motasam Majedy in the video below. Click here to learn more about AugaOne™, the first product in the Auga platform👉 https://lnkd.in/dSvAwxYN #ArgusEye #AugaPlatform #BiopharmaInnovation #RealTimeData #DrugDevelopment #Innovation
-
🚀 At the end of August, the InnovateNordics Stockholm Pitch & Investor Summit took place. Our COO Nathalie Elsässer gave a pitch at the event. This meeting is part of the 2024 InnovativeNordics Acceleration Program led by The Swedish-American Chamber of Commerce - New York, and will soon be held in New York. The Acceleration Program runs from October 1-3, and our COO will be in New York from September 27. We would love to meet you there! Do not hesitate to contact Nathalie to schedule a meeting, and we will make the arrangements. Meeting times are available on September 27 and 30, as well as October 2. We are also available for meetings in Boston the days prior. We hope to see you there! 🌟 #innovation #acceleration #expansion #InnovativeNordics2024
-
ArgusEye omdelade detta
I will be giving a talk about Real-Time Analytical Solution for Optimizing Upstream mAb Bioprocessing at the BioProcess International Conference & Exhibition from September 26 at the Hynes Convention Center in Boston. Make sure to visit ArgusEye in both 900 and talk to Nathalie Elsässer and Ana Pinheiro, Ph.D. to learn more about real-time biosensors for both upstream and downstream bioprocess applications.
-
✨We are thrilled to welcome Fernanda Rebellato to the ArgusEye team! ✨ Fernanda is one of our new R&D Lab Engineers here at ArgusEye. With an expertise in industrial and environmental biotechnology and previous experience working with AugaOne™, she will bring great value to the development team. Welcome to ArgusEye, Fernanda – we are excited to have you onboard! Get to know Fernanda 👇 #welcome #team #expansion #innovation
Liknande sidor
Finansiering
Senaste finansieringsrunda
Okänd serie3 021 787,00 US$